These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33843411)

  • 1. Pregnancy outcome in women with prior placenta accreta spectrum disorders treated with conservative-reconstructive surgery: analysis of 202 cases.
    Palacios-Jaraquemada JM; Basanta N; Labrousse C; Martínez M
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6297-6301. PubMed ID: 33843411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique.
    Palacios-Jaraquemada JM; Fiorillo A; Hamer J; Martínez M; Bruno C
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):275-282. PubMed ID: 31984808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal outcome after conservative-reconstructive surgery for placenta accreta spectrum disorders.
    Palacios-Jaraquemada JM; Basanta N; Fiorillo A; Labrousse C; Martínez M
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):4994-4996. PubMed ID: 33441040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emergency delivery in pregnancies at high probability of placenta accreta spectrum on prenatal imaging: a systematic review and meta-analysis.
    Lucidi A; Janiaux E; Hussein AM; Nieto-Calvache A; Khalil A; D'Amico A; Rizzo G; D'Antonio F
    Am J Obstet Gynecol MFM; 2024 Oct; 6(10):101432. PubMed ID: 39069207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine conservative-resective surgery for selected placenta accreta spectrum cases: Surgical-vascular control methods.
    Aryananda RA; Aditiawarman A; Gumilar KE; Wardhana MP; Akbar MIA; Cininta N; Ernawati E; Wicaksono B; Joewono HT; Dachlan EG; Bachtiar CA; Kurniawati D; Virdayanti DP; Ariani G; Dekker GA; Sulistyono A
    Acta Obstet Gynecol Scand; 2022 Jun; 101(6):639-648. PubMed ID: 35301710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between Number of Prior Cesareans and Early Preterm Delivery in Women with Abnormal Placentation.
    Oben A; Ausbeck EB; Gazi MN; Subramaniam A; Harper LM; Szychowski JM; Tita AT
    Am J Perinatol; 2021 Mar; 38(4):326-331. PubMed ID: 32992353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urological complications in women undergoing Cesarean section for placenta accreta spectrum disorders: systematic review and meta-analysis.
    Lucidi A; Jauniaux E; Hussein AM; Coutinho CM; Tinari S; Khalil A; Shamshirsaz A; Palacios-Jaraquemada JM; D'Antonio F
    Ultrasound Obstet Gynecol; 2023 Nov; 62(5):633-643. PubMed ID: 37401769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified one-step conservative uterine surgery (MOSCUS) versus cesarean hysterectomy in the management of placenta accreta spectrum: A single-center retrospective analysis based on 619 Vietnamese pregnant women.
    Vuong ADB; Pham TH; Pham XTT; Truong DP; Nguyen XT; Trinh NB; Nguyen DV; Nguyen YON; Nguyen TNTN; Ho QN; Nguyen PN
    Int J Gynaecol Obstet; 2024 May; 165(2):723-736. PubMed ID: 38009657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal outcomes in the surgical management of placenta accreta spectrum disorders: a retrospective single-center observational study from 468 Vietnamese pregnancies beyond 28 weeks of gestation.
    Nguyen PN; Vuong ADB; Pham XTT
    BMC Pregnancy Childbirth; 2024 Apr; 24(1):228. PubMed ID: 38566074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter observational survey of management strategies in 442 pregnancies with suspected placenta accreta spectrum.
    van Beekhuizen HJ; Stefanovic V; Schwickert A; Henrich W; Fox KA; MHallem Gziri M; Sentilhes L; Gronbeck L; Chantraine F; Morel O; Bertholdt C; Braun T; Rijken MJ; Duvekot JJ;
    Acta Obstet Gynecol Scand; 2021 Mar; 100 Suppl 1(Suppl 1):12-20. PubMed ID: 33483943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsequent pregnancy outcomes and risk factors following conservative treatment for placenta accreta spectrum: a retrospective cohort study.
    Zhao H; Liu C; Fu H; Abeykoon SDI; Zhao X
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101189. PubMed ID: 37832645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of impact of post-Cesarean section uterine scarring in perinatal diagnosis of placenta accreta spectrum disorder.
    Hussein AM; Elbarmelgy RA; Elbarmelgy RM; Thabet MM; Jauniaux E
    Ultrasound Obstet Gynecol; 2022 Apr; 59(4):474-482. PubMed ID: 34225385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of placenta accreta spectrum (PAS) pathology on neonatal respiratory outcomes in cesarean hysterectomies.
    Munoz JL; Kimura AM; Julia J; Tunnell C; Hernandez B; Curbelo J; Ramsey PS; Ireland KE
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10692-10697. PubMed ID: 36521848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third-trimester ultrasound for antenatal diagnosis of placenta accreta spectrum in women with placenta previa: results from the ADoPAD study.
    Fratelli N; Prefumo F; Maggi C; Cavalli C; Sciarrone A; Garofalo A; Viora E; Vergani P; Ornaghi S; Betti M; Vaglio Tessitore I; Cavaliere AF; Buongiorno S; Vidiri A; Fabbri E; Ferrazzi E; Maggi V; Cetin I; Frusca T; Ghi T; Kaihura C; Di Pasquo E; Stampalija T; Belcaro C; Quadrifoglio M; Veneziano M; Mecacci F; Simeone S; Locatelli A; Consonni S; Chianchiano N; Labate F; Cromi A; Bertucci E; Facchinetti F; Fichera A; Granata D; D'Antonio F; Foti F; Avagliano L; Bulfamante GP; Calì G;
    Ultrasound Obstet Gynecol; 2022 Sep; 60(3):381-389. PubMed ID: 35247287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Outcome analysis of pregnancy termination and expectant treatment in pregnant women with suspected invasive placenta accreta spectrum disorders in the second trimester].
    Chen L; Wang Y; Liang SY; Shi HF; Zhao YY
    Zhonghua Fu Chan Ke Za Zhi; 2023 Jul; 58(7):489-494. PubMed ID: 37474321
    [No Abstract]   [Full Text] [Related]  

  • 16. Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: a systematic review and meta-analysis.
    Pan S; Han M; Zhai T; Han Y; Lu Y; Huang S; Zuo Q; Jiang Z; Ge Z
    BMC Pregnancy Childbirth; 2024 Jul; 24(1):463. PubMed ID: 38969992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and fetal outcome in placenta accreta spectrum (PAS) associated with placenta previa: a retrospective analysis from a tertiary center.
    Varlas VN; Bors RG; Birsanu S; Maxim B; Clotea E; Mihailov M
    J Med Life; 2021; 14(3):367-375. PubMed ID: 34377203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study.
    El Gelany S; Mosbeh MH; Ibrahim EM; Mohammed M; Khalifa EM; Abdelhakium AK; Yousef AM; Hassan H; Goma K; Alghany AA; Mohammed HF; Azmy AM; Ali WA; Abdelraheim AR
    BMC Pregnancy Childbirth; 2019 Aug; 19(1):313. PubMed ID: 31455286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and meta-analysis on placenta accreta spectrum disorders in twin pregnancies: risk factors, detection rate and histopathology.
    DI Girolamo R; Buca D; Galliani C; D'Amico A; CALì G; Lucidi A; Giannini C; Chiarelli F; Liberati M; D'Antonio F
    Minerva Obstet Gynecol; 2023 Feb; 75(1):55-61. PubMed ID: 34328297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of cesarean delivery in placenta accreta: conservative delivery vs. cesarean hysterectomy.
    Alina WB; Elias C; Eran K; Lior F; Nizan M; Gabriel L; Hila LE; Raanan M
    J Perinat Med; 2024 Jan; 52(1):22-29. PubMed ID: 37602708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.